Description

This issue of Vital Signs, released on September 27, 2010, provides a strategic overview of key issues and trends relating to companion diagnostics. Additionally, a company spotlight is provided for Plexxikon, Inc., who focuses on the discovery and development of novel, small molecule pharmaceuticals. Reimbursement and regulatory news from the FDA is also provided for the week of September 6, 2010.